While Bayer’s consumer and crop science divisions continued to slide—both in the fourth quarter and in 2024 overall—the ...

Bayer guided for lower earnings this year as it continues to work through a turnaround plan, but said performance is expected ...

The center, which broke ground in 2023 in the Beijing Economic-Technological Development Area — aka Beijing E-Town — is the ...

Bayer reported Q4 adjusted EPS of $0.28, missing estimates, but sales beat forecasts. The company sees 2025 as a tough year, with growth expected from 2026.

Bayer Aktiengesellschaft ( OTCPK:BAYZF) Q4 2024 Earnings Conference Call March 5, 2025 8:00 AM ET Jost Reinhard - IR Bill Anderson - Chairman & CEO Wolfgang Nickl - CFO Rodrigo Santos - President, ...

German pharmaceutical and agrochemical company Bayer saw profits fall again in 2024 and faces another difficult year ahead, ...

Bayer raised the prospect of a return to earnings growth from 2026 after a decline this year, lifting its shares to a ...